Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Micardis

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Micardis was produced by Boehringer Ingelheim and Astellas.

Boehringer Ingelheim returns to growth after US turnaround

Boehringer Ingelheim returns to growth after US turnaround

Boehringer's heart drug Micardis (telmisartan) continued to suffer the effects of generic competition, with sales down 12.1% to 956m, but 2015 also saw the company's diabetes portfolio making

Humira remains top pharma product, but Sovaldi closes in

Humira remains top pharma product, but Sovaldi closes in Boehringer has seen a similar situation with its heart drug Micardis(telmisartan) that has been losing patent protection for over a year.

Heart drug sales continue downward spiral

Heart drug sales continue downward spiral Finally Boehringer, which saw the largest drop in the top ten table due predominately to the patent loss of Micardis (telmisartan).

Boehringer's sales drop after 'intense and challenging' year

Boehringer's sales drop after 'intense and challenging' year During the year all four of Boehringer's top products saw their global sales decline, most noticeably cardiovascular drug Micardis (telmisartan) and COPD treatment Combivent (ipratropium and albuterol), both of which

Micardis

Micardis campaign. Created by Seven Stones for Boehringer Ingelheim. Therapy area: Cardiovascular

1 2 3 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

RWE Blog 3: Is real-world evidence the holy grail
We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...
What do Healthcare Professionals think about the inclusion of remote selling techniques?
Evolving to a digitally focused pharma / healthcare company - an organisational roadmap...
Drug pricing and competition
Strengthening business competition and reducing anti-competitive practices
How the CMA is tackling high prices for essential drugs...

Infographics